Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation

Background Guideline recommendations for oral anticoagulation (OAC) in patients with atrial fibrillation (AF) are based on CHA2DS2‐VASc score alone. Patients with cardiac implantable electronic devices provide an opportunity to assess how the interaction between AF duration and CHA2DS2‐VASc score in...

Full description

Bibliographic Details
Main Authors: Rachel M. Kaplan, Paul D. Ziegler, Jodi Koehler, Sean Landman, Shantanu Sarkar, Rod S. Passman
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulation
atrial fibrillation
device‐detection
subclinical
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018378

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.018378

Similar Items